×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SANOFI INDIA LTD | 5,263.00 | 821.90 | 5,240.00 | 35.69 | 11,687 | 27.7 |
| MARKSANS PHARMA LTD. | 7096.95 | 1050.67 | 6818.46 | 2.31 | 10244 | 27.9 |
| Vijaya Diagnostic Centre Limit | 1612.46 | 335.33 | 1562.55 | 3.26 | 10203 | 71.9 |
Sanofi India Ltd, with Security Code 500674, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 699.3 | 691.9 | 671.9 | 736.5 | 706.1 | 714.5 | 693.9 | 732.4 | 463.5 | 524.0 |
| Expenses | 538.2 | 510.0 | 505.0 | 506.6 | 527.9 | 506.1 | 506.5 | 513.5 | 347.8 | 404.3 |
| Operating Profit | 161.1 | 181.9 | 166.9 | 229.9 | 178.2 | 208.5 | 187.4 | 218.9 | 115.7 | 119.7 |
| OPM % | 23.04% | 26.29% | 24.84% | 31.22% | 25.24% | 29.17% | 27.01% | 29.89% | 24.96% | 22.84% |
| Other Income | 15.7 | 11.4 | 33.9 | 43.6 | 15.7 | 11.8 | 12.0 | -20.2 | -14.2 | 2.3 |
| Interest | 0.4 | 0.5 | 0.4 | 0.3 | 0.7 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 |
| Depreciation | 10.6 | 10.4 | 10.0 | 9.7 | 9.8 | 9.9 | 10.2 | 10.0 | 9.0 | 9.0 |
| Profit before tax | 165.8 | 182.4 | 176.5 | 245.7 | 183.4 | 210.1 | 188.8 | 215.1 | 111.1 | 112.6 |
| Tax % | 27.4% | 28.2% | 31.3% | 27.7% | 33% | 27.6% | 27.1% | 27.5% | 26% | 27% |
| Net Profit | 120.4 | 130.9 | 130.9 | 190.4 | 122.9 | 152.1 | 137.7 | 136.6 | 103.4 | 82.2 |
| EPS in Rs | 52.28 | 56.84 | 56.84 | 82.67 | 53.37 | 66.08 | 59.79 | 59.31 | 44.9 | 35.69 |
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Sales | 706.1 | 714.6 | 693.9 | 732.4 | 463.5 | 524.0 |
| Expenses | 527.9 | 506.3 | 506.5 | 513.5 | 347.8 | 404.3 |
| Operating Profit | 178.2 | 208.3 | 187.4 | 218.9 | 115.7 | 119.7 |
| OPM % | 25.2% | 29.1% | 27% | 29.9% | 25% | 22.8% |
| Other Income | 15.7 | 11.8 | 12.0 | 6.5 | -14.2 | 2.3 |
| Interest | 0.7 | 0.3 | 0.4 | 0.3 | 0.4 | 0.4 |
| Depreciation | 9.8 | 9.9 | 10.2 | 10.0 | 9.0 | 9.0 |
| Profit before tax | 183.4 | 209.9 | 188.8 | 215.1 | 111.1 | 112.6 |
| Tax % | 33% | 27.6% | 27.1% | 27.5% | 26% | 27% |
| Net Profit | 122.9 | 151.9 | 137.7 | 136.6 | 103.2 | 82.2 |
| EPS in Rs | 53 | 65 | 59 | 59 | 44 | 35 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | -1% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 3% |
| 3 Years: | 4% |
| 1 Year: | -9% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 3% |
| 3 Years: | 4% |
| 1 Year: | -9% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|